The Oasis Health Journal · Submitted July 1, 2026 · 8:15 AM ET
Some of your cells are dead. That is fine, that is normal, that is the plan. The trouble is the cells that are only sort of dead. Not dividing, not dying, just loitering. Scientists call them senescent cells. Everyone else calls them zombie cells, which is more fun and, weirdly, more accurate.
A zombie cell is a retired employee who still badges into the building every morning. It does not do the work. It sits at the desk, eats the snacks, files complaints. In cellular terms it leaks a stew of inflammatory signals (biologists named the mix the SASP), and that stew nudges the healthy cells next to it toward the same early retirement. A few zombie cells, no problem. A whole department of them, and the tissue starts to age.
Which brings us to fisetin, a plant flavonoid and the yellow pigment quietly living inside strawberries. Fisetin is a senolytic, which is a lab-coat word for a compound that talks zombie cells into finally leaving the building.
The strawberry that got a lab coat
In 2018, a team writing in EBioMedicine held a bake-off of ten flavonoids to see which cleared senescent cells best. Fisetin won. Given to aged mice late in life, it extended both median and maximum lifespan and lowered senescence markers across several tissues. The authors described the mechanism as hit and run: fisetin shows up, clears some zombies, and leaves without moving in. It also worked on human tissue in a dish, which is the detail that made the field lean forward.
Then 2025 got specific about muscle. A study in Aging Cell put old mice on an intermittent fisetin schedule, one week on, two weeks off, one week on, which is less daily-vitamin and more occasional deep-clean. The treated mice were less frail and gripped harder, and their muscle showed fewer senescence-related genes switched on. The kicker: those gains landed in the same ballpark as deleting the zombie cells genetically, and as a designer senolytic drug called navitoclax. A strawberry pigment, keeping pace with the pharmaceuticals. Somewhere a chemist is quietly annoyed.
The part where I remind you these are mice
Mice are not tiny people. Every result above happened in animals or in cells on a plate, and 'extends lifespan in mice' is a phrase that has broken a thousand human hearts. The honest 2026 status is that fisetin is one of the most studied natural senolytics we have, and the human trials are still running, not finished. Mayo Clinic has a phase 2 trial testing fisetin in elderly patients with sepsis, and a separate phase 2 trial is testing whether it improves physical function in breast cancer survivors. Interesting, ongoing, unproven. Anyone selling fisetin as a guaranteed longer life is selling you the mouse data with the mouse cropped out.
You cannot eat your way there
Yes, fisetin is in strawberries. It is also the reason a strawberry is not a supplement. A cup of strawberries carries fisetin in the microgram range, and the research doses run up in the grams. That is a gap of a few thousand-fold. You would need to eat the whole produce aisle, daily, forever, and most of it still would not make it in, because fisetin is famously hard to absorb. It barely dissolves in water and your body clears it fast, so a lot of a plain dose just waves at your bloodstream on the way past.
That absorption problem is exactly why the freshness and sourcing of a fisetin supplement matter more than the big number on the front of the bottle. A fragile flavonoid that sat in a warehouse for two years is not doing its best work. This is the unglamorous reason The Oasis of Health sources professional-grade supplements fresh per order instead of stockpiling aging inventory. The shipping runs a little slower. The tradeoff is potency that has not been sunbathing on a shelf since 2024.
Fisetin also rarely works alone. It is a chemical cousin of quercetin, the flavonoid from the original senolytic research, and it often shares a capsule with apigenin in combination senolytic formulas built around the same clear-the-zombies idea. None of these are magic. All of them make more sense as cellular housekeeping than as a fountain of youth.
The tidy version: fisetin is a real senolytic with genuinely striking animal data, a bad absorption habit, and a human story still being written. Promising, not proven. Which is a more interesting place to stand than most of the supplement aisle.
This article is for education only and is not medical advice; talk with a qualified healthcare professional before starting any supplement, especially if you are pregnant, nursing, or taking medication.
Sources
- Murray et al. Intermittent Supplementation With Fisetin Improves Physical Function and Decreases Cellular Senescence in Skeletal Muscle With Aging. Aging Cell (2025).
- Yousefzadeh et al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine (2018).
- A phase II randomized placebo-controlled study of fisetin to improve physical function in breast cancer survivors (TROFFi): rationale and trial design.
- Senolytics To slOw Progression of Sepsis (STOP-Sepsis) in elderly patients: study protocol for a randomized clinical trial.
- Fisetin, In Search of Better Bioavailability: From Macro to Nano Modifications. A Review (2023).
- Fisetin as a senotherapeutic agent: evidence and perspectives for age-related diseases.

Leave a comment